The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients
NCT ID: NCT05168449
Last Updated: 2024-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
86 participants
INTERVENTIONAL
2022-09-17
2023-12-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacist-led Intervention on Hemodialysis Patients' Therapy Adherence
NCT06744738
Patient-Centered Pharmacist Care in the Hemodialysis Unit: A Quasi-Experimental Interrupted Time Series Study
NCT03576404
Clinical Pharmacist-led Inpatient Anticoagulation Stewardship Program
NCT03812848
Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients
NCT06071065
Nurse-led Intervention to Improve Phosphate Binder Adherence
NCT02063490
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recruited patients will be randomly divided in two groups; intervention group and control group, with baseline evaluation of outcomes to be measured.
Control group will be provided with usual care. Intervention group will be provided in addition to the usual care, with an access to the mobile application after a simple training for app usage. Both groups will be followed for a period of 3 months.
The study will include the development, validation and the testing for evaluating the specially designed mobile application.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Control group will be provided with usual care. Intervention group will be provided in addition to the usual care, with an access to the previously described mobile application
No interventions assigned to this group
Intervention Group
Intervention group will be provided in addition to the usual care, with an access to the mobile application
Mobile Application
mobile phone applications directed to chronic kidney disease patients to improve their medication.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mobile Application
mobile phone applications directed to chronic kidney disease patients to improve their medication.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Literate
* Ownership of android smart phone compatible with the application
* Poly-pharmacy
Exclusion Criteria
* Pregnancy due to altered physiology
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shaza Gamal Abdel Fattah Ali Mohamed
Teaching Assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shaza Gamal, Bsc
Role: PRINCIPAL_INVESTIGATOR
Teaching Assistant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Private Clinic
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gamal S, Elseasi AMA, Sabry NA, Farid SF. Impact of pharmacist led mobile application on medication adherence and efficacy in chronic kidney disease. NPJ Digit Med. 2025 May 30;8(1):325. doi: 10.1038/s41746-025-01742-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CL (2871)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.